Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.

P P Piccaluga; G Visani; S A Pileri; S Ascani; T Grafone; A Isidori; M Malagola; C Finelli; G Martinelli; P Ricci

doi:10.1038/sj.leu.2402596

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.

Identifier:nobleid.org/w1/20260515/F702C81B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F702C81B.svg?ark=w1%2F20260515%2FF702C81B)](https://nobleid.org/work/w1/20260515/F702C81B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.

Identifier:nobleid.org/w1/20260515/F702C81B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F702C81B.svg?ark=w1%2F20260515%2FF702C81B)](https://nobleid.org/work/w1/20260515/F702C81B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work